GLYCAM1
| glycosylation dependent cell adhesion molecule-1 | |
|---|---|
| Identifiers | |
| Symbol | GLYCAM1 |
| Entrez | 644076 |
| HUGO | 18023 |
| RefSeq | XM_927461 |
| UniProt | Q8IVK1 |
| Other data | |
| Locus | Chr. 12 q13.2 |
|
WikiDoc Resources for GLYCAM1 |
|
Articles |
|---|
|
Most recent articles on GLYCAM1 |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on GLYCAM1 at Clinical Trials.gov Clinical Trials on GLYCAM1 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on GLYCAM1
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating GLYCAM1 Risk calculators and risk factors for GLYCAM1
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for GLYCAM1 |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Glycosylation-dependent cell adhesion molecule-1 (GLYCAM1) is a proteoglycan ligand expressed on cells of the high endothelial venules in lymph nodes. It is able to bind to the receptor L-selectin during inflammation, acting as a homing beacon for leukocytes expressing the receptor to enter the site of inflammation[1].
External links
- GlyCAM-1 at the US National Library of Medicine Medical Subject Headings (MeSH)